<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Gumshoe &#187; Access Group</title>
	<atom:link href="http://stockgumshoe.com/tag/access-group/feed/" rel="self" type="application/rss+xml" />
	<link>http://stockgumshoe.com</link>
	<description>Secret Teaser Stocks Revealed. Investment Newsletters Reviewed.</description>
	<lastBuildDate>Thu, 24 May 2012 17:35:40 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>&#8220;How to Play Genomics for Potential Triple-Bagger Gains&#8221;</title>
		<link>http://stockgumshoe.com/reviews/firstline-investor-alert/how-to-play-genomics-for-potential-triple-bagger-gains/</link>
		<comments>http://stockgumshoe.com/reviews/firstline-investor-alert/how-to-play-genomics-for-potential-triple-bagger-gains/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 21:21:45 +0000</pubDate>
		<dc:creator>Travis Johnson, Stock Gumshoe</dc:creator>
				<category><![CDATA[Biotech/Medical]]></category>
		<category><![CDATA[Access Group]]></category>
		<category><![CDATA[FirstLine Investor Alert]]></category>
		<category><![CDATA[Genomic Health (GHDX)]]></category>
		<category><![CDATA[Marc Lichtenfeld]]></category>
		<category><![CDATA[oxford club]]></category>
		<category><![CDATA[White Cap Research]]></category>

		<guid isPermaLink="false">http://stockgumshoe.com/?post_type=reviews&#038;p=9377</guid>
		<description><![CDATA[Marc Lichtenfeld, who we&#8217;ve covered a number of times in this space, focuses largely on biotech investments &#8212; he&#8217;s teased a number of them for a variety of different newsletters that he has helmed or contributed to, but it looks like he&#8217;s now launching a new letter from the Oxford Club called FirstLine Investor Alert. [...]]]></description>
		<wfw:commentRss>http://stockgumshoe.com/reviews/firstline-investor-alert/how-to-play-genomics-for-potential-triple-bagger-gains/feed/</wfw:commentRss>
		<slash:comments>17</slash:comments>
		</item>
		<item>
		<title>&#8220;The Next 8,539% Biotech Breakout &#8230; Beginning April 26&#8243;</title>
		<link>http://stockgumshoe.com/reviews/first-access/the-next-8539-biotech-breakout-beginning-april-26/</link>
		<comments>http://stockgumshoe.com/reviews/first-access/the-next-8539-biotech-breakout-beginning-april-26/#comments</comments>
		<pubDate>Tue, 13 Apr 2010 15:36:19 +0000</pubDate>
		<dc:creator>Travis Johnson, Stock Gumshoe</dc:creator>
				<category><![CDATA[Biotech/Medical]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Access Group]]></category>
		<category><![CDATA[First Access]]></category>
		<category><![CDATA[Marc Lichtenfeld]]></category>
		<category><![CDATA[Mt. Vernon Research]]></category>
		<category><![CDATA[Sangamo Biosciences]]></category>

		<guid isPermaLink="false">http://www.stockgumshoe.com/?p=2286</guid>
		<description><![CDATA[Ah, a good old promise of biotech riches &#8212; I haven&#8217;t dug into one of these in ages, nothing beats the wild biotech stocks that can see their share price climb 200% (or fall 90%) on a single bit of news. This tease is from Marc Lichtenfeld, whose biotech stuff we&#8217;ve looked at several times [...]]]></description>
		<wfw:commentRss>http://stockgumshoe.com/reviews/first-access/the-next-8539-biotech-breakout-beginning-april-26/feed/</wfw:commentRss>
		<slash:comments>27</slash:comments>
		</item>
		<item>
		<title>&#8220;The Greatest Little Stock Nobody&#8217;s Ever Heard Of&#8221; (Marc Lichtenfeld)</title>
		<link>http://stockgumshoe.com/reviews/access-group/the-greatest-little-stock-nobodys-ever-heard-of-marc-lichtenfeld/</link>
		<comments>http://stockgumshoe.com/reviews/access-group/the-greatest-little-stock-nobodys-ever-heard-of-marc-lichtenfeld/#comments</comments>
		<pubDate>Tue, 03 Nov 2009 17:24:10 +0000</pubDate>
		<dc:creator>Travis Johnson, Stock Gumshoe</dc:creator>
				<category><![CDATA[Biotech/Medical]]></category>
		<category><![CDATA[Access Group]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Celldex]]></category>
		<category><![CDATA[Marc Lichtenfeld]]></category>

		<guid isPermaLink="false">http://www.stockgumshoe.com/?p=1869</guid>
		<description><![CDATA[Now this is a nice promise: &#8220;If This Stock Doesn&#8217;t Double Between Now and June 25, I&#8217;ll Write You an Apology – Along With a Check for $1,250&#8243; Of course, one assumes that this only applies to the folks who pony up that same $1,250 for a subscription to the Access Research Group newsletter (and, [...]]]></description>
		<wfw:commentRss>http://stockgumshoe.com/reviews/access-group/the-greatest-little-stock-nobodys-ever-heard-of-marc-lichtenfeld/feed/</wfw:commentRss>
		<slash:comments>13</slash:comments>
		</item>
		<item>
		<title>&#8220;Double your money &#8230; Guaranteed&#8221; Access Group</title>
		<link>http://stockgumshoe.com/reviews/access-group/double-your-money-guaranteed-access-group/</link>
		<comments>http://stockgumshoe.com/reviews/access-group/double-your-money-guaranteed-access-group/#comments</comments>
		<pubDate>Wed, 08 Apr 2009 15:55:47 +0000</pubDate>
		<dc:creator>Travis Johnson, Stock Gumshoe</dc:creator>
				<category><![CDATA[Biotech/Medical]]></category>
		<category><![CDATA[Access Group]]></category>
		<category><![CDATA[Electro-Optical Sciences]]></category>
		<category><![CDATA[Marc Lichtenfeld]]></category>
		<category><![CDATA[MELA]]></category>

		<guid isPermaLink="false">http://www.stockgumshoe.com/?p=1339</guid>
		<description><![CDATA[This is an ad that probably many of you have already seen, from Marc Lichtenfeld for his Access Group newsletter. And yes, like so many ads do, they&#8217;re guaranteeing that you&#8217;ll double your money if you invest in this idea. Which gives me a chance for a quick little digression before we dig into the [...]]]></description>
		<wfw:commentRss>http://stockgumshoe.com/reviews/access-group/double-your-money-guaranteed-access-group/feed/</wfw:commentRss>
		<slash:comments>9</slash:comments>
		</item>
		<item>
		<title>&#8220;Hunt Down Cancer Cells and Zap them Dead&#8221; Access Group</title>
		<link>http://stockgumshoe.com/reviews/access-group/hunt-down-cancer-cells-and-zap-them-dead-access-group/</link>
		<comments>http://stockgumshoe.com/reviews/access-group/hunt-down-cancer-cells-and-zap-them-dead-access-group/#comments</comments>
		<pubDate>Fri, 05 Sep 2008 14:36:20 +0000</pubDate>
		<dc:creator>Travis Johnson, Stock Gumshoe</dc:creator>
				<category><![CDATA[Access Group]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Marc Lichtenfeld]]></category>
		<category><![CDATA[SNTA]]></category>
		<category><![CDATA[Synta Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.stockgumshoe.com/?p=510</guid>
		<description><![CDATA[Today&#8217;s teaser ad is from Marc Lichtenfeld and his Access Group &#8211; they specialize in part on medical and biotech stocks, and the first two ads we&#8217;ve looked at them are in that area. The first one was for the &#8220;$4 Cancer Detection Device that could go to $196,&#8221; which you might remember turned out [...]]]></description>
		<wfw:commentRss>http://stockgumshoe.com/reviews/access-group/hunt-down-cancer-cells-and-zap-them-dead-access-group/feed/</wfw:commentRss>
		<slash:comments>30</slash:comments>
		</item>
		<item>
		<title>Access Group: &#8220;$4.75 Cancer Detection Device co. could got to $196&#8243;</title>
		<link>http://stockgumshoe.com/reviews/access-group/access-group-475-cancer-detection-device-co-could-got-to-59/</link>
		<comments>http://stockgumshoe.com/reviews/access-group/access-group-475-cancer-detection-device-co-could-got-to-59/#comments</comments>
		<pubDate>Tue, 25 Mar 2008 04:04:28 +0000</pubDate>
		<dc:creator>Travis Johnson, Stock Gumshoe</dc:creator>
				<category><![CDATA[Biotech/Medical]]></category>
		<category><![CDATA[Access Group]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Electro-Optical Sciences]]></category>
		<category><![CDATA[Marc Lichtenfeld]]></category>
		<category><![CDATA[MELA]]></category>

		<guid isPermaLink="false">http://www.stockgumshoe.com/2008/03/access-group-475-cancer-detection-device-co-could-got-to-59.html</guid>
		<description><![CDATA[This one comes in from what looks to be a new newsletter service called &#8220;The Access Group&#8221; that will run you $2,750 a year. Phew. This is a service that they claim will enable individual investors to get access to the kind of research hedge fund companies used to pay these analysts $30,000 a year [...]]]></description>
		<wfw:commentRss>http://stockgumshoe.com/reviews/access-group/access-group-475-cancer-detection-device-co-could-got-to-59/feed/</wfw:commentRss>
		<slash:comments>21</slash:comments>
		</item>
	</channel>
</rss>

